Natco Pharma to focus to scale up Cancer treatment biz in China: MD VC Nannapaneni Medical Dialogues Bureau12 Aug 2019 12:26 PM ISTNew Delhi: Natco Pharma is focusing on filing of cancer treatment drugs in China, the world's second largest pharmaceutical market, as part of its...
Canada enacts drug price crackdown, in blow to pharmaceutical industry Medical Dialogues Bureau11 Aug 2019 9:00 AM ISTThe changes are the biggest reform to Canada's drug price regime since 1987 and could eventually cut the earnings of drugmakers in the United States,...
Zydus Cadila total income up by 21 percent to Rs 3496 crore in Q1 Medical Dialogues Bureau10 Aug 2019 12:43 PM ISTDuring the quarter, Zydus Cadila entered into a marketing alliance with SIFI, the Italian leader in the development of therapeutic solutions for...
Bayer buys BlueRock in USD 600 million bet on stem cell therapies Medical Dialogues Bureau9 Aug 2019 9:00 AM ISTFRANKFURT: German drugmaker Bayer is paying up to $600 million for full control of cell therapy developer BlueRock Therapeutics, stepping up...
Bayer Rivaroxaban tablets win CDSCO Committee nod for waiver of local clinical trial; directed to carry Phase IV trial Medical Dialogues Bureau8 Aug 2019 5:28 PM ISTNew Delhi: The apex drug regulatory body, Central Drugs Standard Control Organisation's (CDSCO) Technical Committee has recommended for grant of...
Cadila Healthcare gets OAI letter from USFDA for Moraiya facility Medical Dialogues Bureau8 Aug 2019 10:00 AM ISTThe company has received a letter from the USFDA classifying the inspection conducted at its Moraiya facility from April 22 to May 3 as OAI, Cadila...
GSK ends Ebola vaccine RnD; transfers license to US institute Medical Dialogues Bureau8 Aug 2019 9:30 AM ISTGSK had put its Ebola vaccine work on hold after it was unable to progress the product through the final stage, or Phase III, clinical trials toward...
Novartis concealed data problem before seeking approval for USD 2.1 million gene therapy Zolgensma: USFDA Medical Dialogues Bureau8 Aug 2019 9:15 AM ISTThe FDA said in a statement that AveXis Inc., the Novartis AG subsidiary that manufactures Zolgensma, told the agency five weeks after the approval of...
Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President Farhat Nasim8 Aug 2019 9:00 AM ISTPuneet Srivastava will lead the Sales and Marketing function at a group level. Prior to joining Paras Healthcare, Srivastava was associated with the...
Granules India arm wins USFDA approval for stimulant drug Amphetamine Sulfate tablets Medical Dialogues Bureau7 Aug 2019 9:30 AM ISTAmphetamine Sulfate tablets is a generic version of Arbor Pharmaceuticals LLC's Evekeo tablets in similar strength, it added.New Delhi: Drug firm...
Natco Pharma gets EIR from USFDA for Kothur facility Medical Dialogues Bureau6 Aug 2019 4:35 PM ISTNew Delhi: Drug firm Natco Pharma on Monday said it has received establishment inspection report (EIR) from the US health regulator for its Kothur...
Zydus Cadila completes phase III trial of Diabetes drug Lipaglyn in India Medical Dialogues Bureau5 Aug 2019 10:00 AM ISTSaroglitazar Magnesium was launched in India during September 2013, under the brand name 'Lipaglyn', for the treatment of hypertriglyceridemia and...
